MICHELLE A.T. HILDEBRANDT's research topics

MICHELLE A.T. HILDEBRANDT

Concepts (451)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with MICHELLE A.T. HILDEBRANDT's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that MICHELLE A.T. HILDEBRANDT has written about over time.

Carcinoma, Non-Small-Cell Lung, 13 publications between 2009 and 2015, average publication date June 2012. Lung Neoplasms, 15 publications between 2009 and 2018, average publication date December 2012. Genetic Variation, 17 publications between 2007 and 2020, average publication date March 2013. MicroRNAs, 9 publications between 2010 and 2023, average publication date December 2013. Polymorphism, Single Nucleotide, 67 publications between 2004 and 2023, average publication date May 2014. Genotype, 29 publications between 2009 and 2023, average publication date October 2014. Genetic Predisposition to Disease, 53 publications between 2007 and 2023, average publication date November 2015. Neoplasms, Glandular and Epithelial, 11 publications between 2013 and 2017, average publication date December 2015. Ovarian Neoplasms, 33 publications between 2011 and 2022, average publication date July 2016. Genome-Wide Association Study, 31 publications between 2009 and 2023, average publication date September 2016. Colorectal Neoplasms, 6 publications between 2012 and 2020, average publication date September 2016. MAP Kinase Signaling System, 2 publications between 2015 and 2018, average publication date January 2017. Quantitative Trait Loci, 11 publications between 2013 and 2021, average publication date June 2017. beta Catenin, 3 publications between 2015 and 2021, average publication date September 2017. Wnt Signaling Pathway, 3 publications between 2015 and 2021, average publication date September 2017. Cardiotoxicity, 4 publications between 2017 and 2023, average publication date December 2019. Multiple Myeloma, 10 publications between 2008 and 2023, average publication date August 2020. Anthracyclines, 7 publications between 2017 and 2024, average publication date September 2020. Cancer Survivors, 4 publications between 2017 and 2023, average publication date November 2020.

Carcinoma, Non-Small-Cell Lung
Lung Neoplasms
Genetic Variation
MicroRNAs
Polymorphism, Single Nucleotide
Genotype
Genetic Predisposition to Disease
Neoplasms, Glandular and Epithelial
Ovarian Neoplasms
Genome-Wide Association Study
Colorectal Neoplasms
MAP Kinase Signaling System
Quantitative Trait Loci
beta Catenin
Wnt Signaling Pathway
Cardiotoxicity
Multiple Myeloma
Anthracyclines
Cancer Survivors

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
Carcinoma, Non-Small-Cell Lung	13	2009	2015	June 2012
Lung Neoplasms	15	2009	2018	December 2012
Genetic Variation	17	2007	2020	March 2013
MicroRNAs	9	2010	2023	December 2013
Polymorphism, Single Nucleotide	67	2004	2023	May 2014
Genotype	29	2009	2023	October 2014
Genetic Predisposition to Disease	53	2007	2023	November 2015
Neoplasms, Glandular and Epithelial	11	2013	2017	December 2015
Ovarian Neoplasms	33	2011	2022	July 2016
Genome-Wide Association Study	31	2009	2023	September 2016
Colorectal Neoplasms	6	2012	2020	September 2016
MAP Kinase Signaling System	2	2015	2018	January 2017
Quantitative Trait Loci	11	2013	2021	June 2017
beta Catenin	3	2015	2021	September 2017
Wnt Signaling Pathway	3	2015	2021	September 2017
Cardiotoxicity	4	2017	2023	December 2019
Multiple Myeloma	10	2008	2023	August 2020
Anthracyclines	7	2017	2024	September 2020
Cancer Survivors	4	2017	2023	November 2020

HILDEBRANDT's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (451)

Explore

Co-Authors (73)

Explore

Similar People (60)

Explore

Same Department

Explore